APA (7th ed.) Citation

Burris, H. A., Berlin, J., Arkenau, T., Cote, G. M., Lolkema, M. P., Ferrer-Playan, J., . . . de Bono, J. (2024). A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours. British Journal of Cancer, 130(7), 1131. https://doi.org/10.1038/s41416-023-02436-2

Chicago Style (17th ed.) Citation

Burris, Howard A., et al. "A Phase I Study of ATR Inhibitor Gartisertib (M4344) as a Single Agent and in Combination with Carboplatin in Patients with Advanced Solid Tumours." British Journal of Cancer 130, no. 7 (2024): 1131. https://doi.org/10.1038/s41416-023-02436-2.

MLA (9th ed.) Citation

Burris, Howard A., et al. "A Phase I Study of ATR Inhibitor Gartisertib (M4344) as a Single Agent and in Combination with Carboplatin in Patients with Advanced Solid Tumours." British Journal of Cancer, vol. 130, no. 7, 2024, p. 1131, https://doi.org/10.1038/s41416-023-02436-2.